Navigation Links
Succeed in a World of Shared Savings and Capitation, New Life Science Webinar Hosted by Xtalks
Date:3/7/2013

Toronto, Canada (PRWEB) March 07, 2013

Xtalks today announced a webinar aimed at ACO’s and Shared Saving participants that need to manage their population’s risk to improve outcomes and reduce costs. In the webinar, attendees will learn how organizations, such the ONC sponsored Colorado Beacon Consortium (CBC), are using IndiGO, a clinical decision support tool, to optimize the cost and quality objectives in their population-based programs.

David Eddy, MD, PhD, Founder and CMO Emeritus of Archimedes Inc., and a pioneer in evidence-based medicine, will demonstrate how IndiGO uses individualized guidelines to identify patients at risk and calculate the benefit from medication and lifestyle changes. Sharing the results from a pilot study in Hawaii, he will illustrate how use of IndiGO increased adherence dramatically, and showed a positive ROI for KP.

After the introduction, Patrick Gordon MPA, Associate Vice President of Rocky Mountain Health Plans, will discuss how IndiGO is currently being used at the point-of-care to improve outcomes and reduce costs. Patrick will also discuss how IndiGO is being used to support the Colorado Beacon Consortium’s efforts surrounding CMMI’s Comprehensive Primary Care Initiative.

David Kendrick, MD, MPH, CEO of MyHealth Access Network will discuss their implementation of IndiGO. MyHealth’s health information exchange platform serves an entire region with dozens of health systems and thousands of doctors, and provides risk assessments updated daily on more than 800,000 people.

For more information about this event or to register, visit: http://xtks.in/xto577-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10499381.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmaDirections Succeeds Through its Client’s Successes: Cortendo Receives Positive Orphan Drug Opinion from EMA for NormoCort for Cushing’s Disease
2. Dyadic International To Present At World Biofuels Markets
3. QualityStar Presenting at Biomarkers & Diagnostics World Congress
4. uniQure Named to MIT Technology Reviews 2013 50 Disruptive Companies List Recognizing Worlds Most Innovative Companies
5. Rigaku introduces the world’s most comprehensive biological SAXS system for the home lab
6. New world record efficiency for thin film silicon solar cells
7. US Technologist Extrapolates Future of Connected World in Sci-Fi Book Series Published by Capscovil
8. ResearchMoz: DSL Chips Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018 - Market Research Report
9. ARAMARK Introduces Worlds First Reusable Validated Sterile Goggle That Remains Clear When Irradiated
10. Spectrum Announces bioWorld Distribution Agreement
11. Fertility Associates of Memphis, World-Renowned Expert in Infertility, Presents Findings to European Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):